Van Hulzen Asset Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,567
Closed -$1.81M 341
2024
Q1
$1.81M Buy
5,567
+96
+2% +$23.6K 0.12% 123
2023
Q4
$1.04M Sell
5,471
-2,209
-29% -$417K 0.07% 153
2023
Q3
$1.53M Buy
7,680
+6,124
+394% +$1.45M 0.12% 119
2023
Q2
$444K Sell
1,556
-1,035
-40% -$287K 0.04% 196
2023
Q1
$562K Buy
+2,591
New +$505K 0.05% 165

Other funds holding SWAV

Van Hulzen Asset Management's SWAV Position: Q2 2024 in Review

Van Hulzen Asset Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 5,567 shares — an estimated $1.81M sold.

Van Hulzen Asset Management first reported a position in SWAV in Q1 2023 and held it in 5 quarters. The position peaked at $1.81M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Van Hulzen Asset Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Van Hulzen Asset Management sold 5,567 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $1.81M.
  • Van Hulzen Asset Management first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2023 and held it in 5 quarters.
  • Van Hulzen Asset Management's Shockwave Medical, Inc. Common Stock position peaked at $1.81M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Van Hulzen Asset Management's 13F filing for Q2 2024, filed 7 Aug 2024.